← Open Payments lookup

LILY SMOLINSKI: Open Payments

NPI 1821511809 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$663 in 42 payments from 14 companies in 2025. Trend: 2023 $559 · 2024 $778 · 2025 $663

Food & beverage: $663
CompanyPaymentsAmount
Novo Nordisk Inc15$175
Lilly USA, LLC5$91
GlaxoSmithKline, LLC.3$51
Exact Sciences Corporation3$50
AstraZeneca Pharmaceuticals LP3$47
Otsuka America Pharmaceutical, Inc.2$45
ABBVIE INC.2$42
Celltrion USA Inc.2$35
Boehringer Ingelheim Pharmaceuticals, Inc.2$33
Takeda Pharmaceuticals U.S.A., Inc.1$25

Products named: Ozempic, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE, Cologuard Collection Kit, Wegovy, REXULTI, VEGZELMA.

Industry payments across TX — which companies pay providers there.